Brief: Targovax Releases Update For Mesothelioma Trial Combining ONCOS-102 And Chemotherapy

Circio Holding ASA

04/05/2020 06:06

May 4 (Reuters) - Targovax ASA  TRVX.OL :
    * TARGOVAX RELEASES UPDATE FOR MESOTHELIOMA TRIAL COMBINING
ONCOS-102 AND CHEMOTHERAPY
    * IMMUNE ACTIVATION IS FURTHER VALIDATED IN ONCOS-102
TREATED
GROUP
    * FIRST LINE MESOTHELIOMA REMAINS FOCUS FOR NEXT PHASE OF
DEVELOPMENT

Source text for Eikon:  ID:nWkrb5HT2N 
Further company coverage:  TRVX.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))